Criteria for symptom remission revisited: A study of patients affected by schizophrenia and schizoaffective disorders

BMC Psychiatry

Volumn 13, Issue , 2013, Pages

  Pinna, Federica ^a   Tusconi, Massimo ^a   Bosia, Marta ^b,c   Cavallaro, Roberto ^b   Carpiniello, Bernardo ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c SCUOLA UNIVERSITARIA SUPERIORE IUSS PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; OUTPATIENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; REMISSION; REMISSION IN SCHIZOPHRENIA WORKING GROUP CRITERIA; SCHIZOAFFECTIVE PSYCHOSIS; SENSITIVITY AND SPECIFICITY; SYMPTOM;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REMISSION INDUCTION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84884769782     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-13-235     Document Type: Article

References (37)

1. Lysaker PA, Roe D, Buck KD. Recovery and wellness amidst schizophrenia: definitions, evidence, and the implications for clinical practice. J Am Psych Nurs Ass 2010, 16:36-42.
2. Lysaker PA, Taylor A, Miller A, Beattie N, Strasburger A, Davis LW. The scale to assess narrative development: association with other measures of self and readiness for recovery in schizophrenia spectrum disorders. J Nerv Ment Dis 2006, 194:223-225. 10.1097/01.nmd.0000202512.54587.34, 16534441.
3. Slade M. Personal recovery and mental illness: a guide for mental health professionals 2009, Cambridge UK: Cambridge University Press.
4. Roe D, Mashiach-Eizenberg M, Lysaker PH. The relation between objective and subjective domains of recovery among persons with schizophrenia-related disorders. Schiz Res 2011, 131:133-138.
5. Nasrallah HA, Lasser R. Improving patients' outcomes in schizophrenia: achieving remission. J Psychopharmacol 2006, 20(6 Suppl):57-61. 10.1177/1359786806071248, 17046987.
6. Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005, 162:441-449. 10.1176/appi.ajp.162.3.441, 15741458.
7. Van Os J, Burns T, Cavallaro E, Leucht S, Peuskens J, Helldin L, Bernardo M, Arango C, Fleishhacker W, Lachaux B, Kane JM. Standardized remission criteria in schizophrenia. Acta Psych Scand 2006, 113:91-95.
8. Emsley R, Chiliza B, Asmal L, Lelhoenya K. The concepts of remission and recovery in schizophrenia. Curr Opin Psychiatry 2011, 24:114-121.
9. AlAqueel B, Margolese HC. Remission in schizophrenia: critical and systematical review. Harv Rev Psychiatry 2012, 20:281-297. 10.3109/10673229.2012.747804, 23216066.
10. Lambert M, Karow A, Leucht S, Schimmelmann BG, Naber D. Remission in Schizophrenia: validity, frequency, predictors and patients' perspectives 5 years later. Dialogues Clin Neurosci 2010, 12:393-407. 3181974, 20954433.
11. Karow A, Moritz S, Lambert M, Schottle D. Naber D and EGOFORS initiative, remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia. Eur Psychiatry 2012, 27:401-405. 10.1016/j.eurpsy.2011.01.012, 21570262.
12. Oorshot M, Lataster T, Thewissen V, Lardinois M, van Os J, Delespaul PA, Myin-Germeys I. Symptomatic remission in psychosis and real-life functioning. Br J Psychiatry 2012, 201:215-220. 10.1192/bjp.bp.111.104414, 22743843.
13. Carpiniello B, Pinna F, Tusconi M, Zaccheddu E, Fatteri F. Gender differences in remission and recovery of schizophrenic and schizoaffective patients: preliminary results of prospective cohort study. Schiz Res Treat 2012, 2012:576369. 10.1155/2012/576369.
14. First MB, Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM IV Axis I Disorders (SCID-I) 2000, Firenze: Organizzazioni Speciali, Versione Italiana a cura di Mazzi F, Morosini P, De Girolamo G, Lusetti M, Guaraldi P.
15. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin L. Structured Clinical Interview for DSM IV Axis II Personality Disorders 2003, Firenze: Organizzazioni Speciali, Versione Italiana a cura di Mazzi F, Morosini P, De Girolamo G, Lusetti M, Guaraldi P.
16. First MB, Spitzer RL, Williams JBW, Gibbon M. Structured clinical interview for DSM IV axis I disorders-resarch version (SCID-I, version 2. 0) 1996, New York: Biometrics Research Department, New York State Psychiatric Institute.
17. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin L. Structured clinical interview for DSM IV axis II personality disorders - research version (SCID II, version 2.0) 1996, New York: Biometrics Research Department, New York State Psychiatric Institute.
18. Pancheri P, Brugnoli R, Carilli L, Delle Chiaie R, Marconi PL, Petrucci RM. Valutazione dimensionale della sintomatologia schizofrenica. Validazione della versione italiana della scala per la valutazione dei sintomi positivi e negativi (PANSS). Giorn Ital Psicopat 1995, 1:60-75.
19. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276. 10.1093/schbul/13.2.261, 3616518.
20. Kay SR, Opler RA, Fiszbein A. The structured clinical interview for positive and negative syndromes of schizophrenia. Versione Italiana a cura di Migone P 1999, Parma: Università di Parma.
21. Kay SR, Opler RA, Fiszbein A. The structured clinical interview for positive and negative syndromes of schizophrenia 1992, New York: Multi-Health Systems.
22. Kay SR, Opler RA, Fiszbein A, Ramirez PM. Positive and negative syndrome scale (PANSS) technical manual 2006, New York: Multi-Health System.
23. Wallwork RS, Fortgang R, Hashimoto R, Weingerger DR, Dickinson B. Searching for a consensus five-factor model of the positive and negative scale for schizophrenia. Schizophr Res 2012, 137:246-250. 10.1016/j.schres.2012.01.031, 3351536, 22356801.
24. Haro JM, Kamath SA, Ochoa S, et al. The clinical global impression-schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand 2003, 416(Suppl):16-23.
25. Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe PM, Coughnenour L. The brief assessment of cognition in schizophrenia: reliability, sensitivity and comparison with a standardized neurocognitive battery. Schizophr Res 2004, 68:283-297. 10.1016/j.schres.2003.09.011, 15099610.
26. Anselmetti S, Poletti P, Ermoli E, Bechi M, Cappa S, Venneri A, Smeraldi E, Cavallaro R. The brief assessment of cognition in schizophrenia. Normative data for the Italian population. Neurol Sci 2008, 29:85-92. 10.1007/s10072-008-0866-9, 18483705.
27. Folstein MF, Folstein SE, McHugh PR. " Mini mental state" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198. 10.1016/0022-3956(75)90026-6, 1202204.
28. Measso G, Cavarzeran F, Zappalà G, Lebowitz BD, Crook TH, Pirozzolo FS, Amaducci L, Massari D, Grigoletto F. The mini mental state examination. Normative study of an Italian random sample. Dev Neuropsychol 1993, 9:77-85.
29. Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R. Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 2000, 2000(101):323-329.
30. Cassidy CM, Norman R, Manchanda R, Schmitz N, Malla A. Testing definitions of symptom remission. Schizophr Bull 2010, 36:1001-1008. 10.1093/schbul/sbp007, 2930352, 19321629.
31. Van Os J, Drukker MA, Campo J, Meijer J, Back M, Delespaul P. Validation of remission criteria for schizophrenia. Am J Psychiatry 2006, 163:2000-2002. 10.1176/appi.ajp.163.11.2000, 17074953.
32. Beintinger R, Lin J, Kissling W, Leucht S. Comparative remission frequencies of schizophrenic patients using various remission criteria. Prog Neuropshychopharmacol Biol Psychiatry 2008, 32:1643-1651.
33. Opler MGA, Yang LH, Caleo S, et al. Statistical validation of the criteria for symptom remission in schizophrenia: preliminary findings. BMC Psychiatry 2007, 7:35. 10.1186/1471-244X-7-35, 1949820, 17650312.
34. Green MF, Kermn RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the " right stuff" ?. Schizophr Bull 2000, 26:119-136. 10.1093/oxfordjournals.schbul.a033430, 10755673.
35. Brissos S, Videira Dias V, Balanzà-Martinez V, Carita AI, Figueira ML. Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance. Schizophr Res 2011, 129:133-136. 10.1016/j.schres.2011.04.001, 21514793.
36. McGurk SR. Neurocognition as a determinant of employments status in schizophrenia. J Psychiatr Pract 2000, 6:190-196. 10.1097/00131746-200007000-00002, 15990484.
37. Bottlender R, Strauss A, Moller HJ. Association between psychopathology and problems of psychosocial functioning in the long term outcome of patients diagnosed with schizophrenic, schizoaffective and affective disorders. Eur Arch Psychiatry Clin Neurosci 2013, 263:85-92. 10.1007/s00406-012-0335-6, 22722960.